Literature DB >> 11916760

Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes.

Sunmin Park1, Soo Bong Choi.   

Abstract

BACKGROUND: Most Koreans with type 2 diabetes are insulin deficient and insulin resistant. Continuous subcutaneous insulin infusion (CSII) provides a suitable amount of insulin to overcome insulin deficiency and achieve near-normal blood glucose concentrations. Our previous study showed, however, that CSII does not reduce oxidative stress even though it normalizes blood glucose concentrations.
OBJECTIVE: The purpose of this study was to determine whether CSII plus alpha-tocopherol supplementation for 2 mo would alter oxidative stress in Korean patients with type 2 diabetes.
DESIGN: Ninety-eight subjects received CSII plus either 200 mg alpha-tocopherol/d (n = 48) or a placebo (n = 50) for 2 mo. The general characteristics (age, duration of diabetes, body mass index, and blood glucose concentrations) of the 2 groups were not significantly different.
RESULTS: Fasting and postprandial blood glucose concentrations of all subjects were normalized after CSII. Fasting plasma insulin concentrations did not differ significantly between the 2 groups after CSII. Lipid peroxide concentrations in plasma and red blood cells decreased and alpha-tocopherol concentrations in plasma and red blood cells increased after alpha-tocopherol supplementation. However, these changes were not affected significantly by CSII. Plasma vitamin C concentrations increased significantly after CSII plus alpha-tocopherol supplementation. However, the activities of antioxidant enzymes in red blood cells did not change significantly after CSII plus alpha-tocopherol supplementation.
CONCLUSION: alpha-Tocopherol supplementation was beneficial in decreasing blood lipid peroxide concentrations without altering antioxidant enzyme activities in Korean patients with type 2 diabetes treated with CSII.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916760     DOI: 10.1093/ajcn/75.4.728

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  6 in total

1.  Could nutrient supplements provide additional glycemic control in diabetes management? A systematic review and meta-analysis of randomized controlled trials of as an add-on nutritional supplementation therapy.

Authors:  Yoonhye Kim; Yun Kyoung Oh; Junhee Lee; Eunyoung Kim
Journal:  Arch Pharm Res       Date:  2022-03-18       Impact factor: 4.946

2.  The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus.

Authors:  Zdenek Jankovec; Daniela Cechurova; Michal Krcma; Silvie Lacigova; Michal Zourek; Zdenek Rusavy
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 3.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

4.  Various Effects of Omega 3 and Omega 3 Plus Vitamin E Supplementations on Serum Glucose Level and Insulin Resistance in Patients with Coronary Artery Disease.

Authors:  Somayeh Saboori; Mahmoud Djalali; Esmaeil Yousefi Rad; Ebrahim Nematipour; Ali Akbar Saboor-Yaraghi; Mohammad Hassan Javanbakht; Mohammad Reza Eshraghian; Atena Ramezani; Fariba Koohdani
Journal:  Iran J Public Health       Date:  2016-11       Impact factor: 1.429

5.  Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials.

Authors:  Maria E Balbi; Fernanda S Tonin; Antonio M Mendes; Helena H Borba; Astrid Wiens; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  Diabetol Metab Syndr       Date:  2018-03-14       Impact factor: 3.320

6.  Influence of vitamin E supplementation on glycaemic control: a meta-analysis of randomised controlled trials.

Authors:  Renfan Xu; Shasha Zhang; Anyu Tao; Guangzhi Chen; Muxun Zhang
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.